In routine MRD monitoring, how often are tests typically performed?

In routine MRD monitoring, how often are tests typically performed?

• A. Every 1-2 months
• B. Every 3-6 months
• C. Every 12 months
• D. Every 6-12 weeks

Answer: (B)

MRD monitoring is about spotting tiny amounts of residual cancer after treatment so relapse can be detected early without overburdening patients. In routine surveillance after achieving remission, tests are typically performed every three to six months. This frequency balances catching relapse in a timely manner with practical considerations like patient burden and healthcare resources. More frequent testing is usually reserved for active treatment or high-risk situations, while testing only once a year could miss early relapse. So, the standard interval is every three to six months.

MRD monitoring is about spotting tiny amounts of residual cancer after treatment so relapse can be detected early without overburdening patients. In routine surveillance after achieving remission, tests are typically performed every three to six months. This frequency balances catching relapse in a timely manner with practical considerations like patient burden and healthcare resources. More frequent testing is usually reserved for active treatment or high-risk situations, while testing only once a year could miss early relapse. So, the standard interval is every three to six months.